Marburg virus


Also found in: Dictionary, Thesaurus, Medical, Legal, Financial, Acronyms, Wikipedia.
Related to Marburg virus: Ebola virus

Marburg virus:

see hemorrhagic feverhemorrhagic fever
, any of a group of viral diseases characterized by sudden onset, muscle and joint pain, fever, bleeding, and shock from loss of blood. Bleeding occurs in the form of leakage from capillaries in the internal organs and the skin and mucous membranes.
..... Click the link for more information.
.

Marburg virus

[′mär‚bu̇rg ‚vī·rəs]
(virology)
A large virus transmitted to humans by the grivet monkey (Cercopithecus aethiops).
Mentioned in ?
References in periodicals archive ?
Australian traveler is exposed to Marburg virus, apparently in Zimbabwe.
88% Death rate among the 374 people infected by Marburg virus in an outbreak in Angola last year
Epidemiologic investigation of Marburg virus disease, southern Africa, 1975.
Previous pre-clinical studies using the compounds had demonstrated protection against Marburg virus in mouse and guinea pig models.
The discovery of NPC1's crucial role in Ebola infection raises the possibility that Ebola and Marburg virus outbreaks could be thwarted by a drug that blocks the action of NPC1.
Marburg virus (MARV) and Ebola virus, members of the family Filoviridae, cause outbreaks of severe hemorrhagic fever in Africa.
Last week the company announced the presentation of successful preclinical results in Ebola virus and in Marburg virus.
Bavari also presented data for two studies evaluating NEUGENE PLUS therapeutics in the treatment of mice and guinea pigs exposed to different strains of the Marburg virus.
Ebola and Marburg virus outbreaks typically occur in resource poor areas in Sub-Saharan Africa, although rare cases have occurred in the United States, Europe and the Philippines.
The risk for transmission of Marburg virus is assumed to increase with the intensity of physical contact and the amount of body fluids shed, as shown for Ebola virus (5).
The focus of the agreement is to explore the therapeutic efficacy of the Aethlon Hemopurifier[R] against viral hemorrhagic fever (VHF) targets, including, but not limited to Ebola Virus, Marburg Virus, Lassa Virus, and Machupo Virus.
GenPhar's vaccine development program is aggressively achieving milestones against viruses such as HIV, hepatitis B and C virus, influenza, and potential bioterror agents such as the hemorrhagic fevers caused by Ebola and Marburg virus, and dengue fever.